Unveiling surfactant protein-A dynamics in human fetal lung development: histological and immunohistochemical insights from Myanmar
, 234, 5
Abstract
Background: Surfactant protein-A (SP-A) is the most prevalent protein in the pulmonary surfactant system and it is expressed in Type II alveolar epithelial cells. Materials and methods: We evaluated SP-A expression in 92 fetal human lungs at various gestational ages in Myanmar (Burma) using hematoxylin and eosin staining and immunohistochemical assays. Results: We detected tubular structures in the fetal lungs during the canalicular stage of development at gestational weeks 22–25. Bronchioles were detected between 26–27 and 28–33 weeks, when primitive alveoli were evident. At 34–40 weeks, clusters of alveolar sacs opened from the alveolar ducts during the saccular development stage. At 40–44 weeks, extremely thin alveolar walls resembled sections of adult lungs. Type II cells secreting surfactant were undetectable at 22–25 weeks, but became detectable from 26 weeks, and the abundance of Type II cells increased after 28 weeks. Surfactant spread throughout the alveoli at 34 weeks. Because the positivity index of these cells significantly correlated with a gestational age of 26–33 weeks, we established a formula to estimate gestational age. Conclusions: Our findings improve understanding of fetal lung development and maturity, and provide valuable insights into the diagnosis and management of respiratory disorders among premature infants in Myanmar.
Keywords: surfactant protein-Ahuman fetal lunghistologyimmunohistochemistryMyanmar
References
- Ankolekar V, Bangera H, Hosapatna M, et al. Developmental stages in fetal lung at different gestational ages — a histological study. J Basic Appl Res Int. 2015; 7(1): 7–15.
- Arey LB. Human histology: a textbook in outline form. WB Saunders Company, Philadelphia 1974.
- Askin FB, Kuhn C. The cellular origin of pulmonary surfactant. Lab Invest. 1971; 25(3): 260–268.
- Betz P, Nerlich A, Wilske J, et al. Determination of fetal age by immunohistochemical estimation of surfactant-producing alveolar type II cells. Forensic Sci Int. 1992; 53(2): 193–202.
- Bewick V, Cheek L, Ball J. Statistics review 7: Correlation and regression. Crit Care. 2003; 7(6): 451–459.
- Cai P, You Y, Jin ZW, et al. Three-dimensional analysis of the segmental arrangement of lower lung lobes in human fetuses: is this arrangement a miniature version of adult morphology? J Anat. 2020; 236(6): 1021–1034.
- Campiche MA, Gautier A, Hernandez EI, et al. An electron microscope study of the fetal development of human lung. Pediatrics. 1963; 32: 976–994.
- Cau F, Pisu E, Gerosa C, et al. Interindividual variability in the expression of surfactant protein A and B in the human lung during development. Eur J Histochem. 2016; 60(3): 2678.
- Deutsch GH, Pinar H. Prenatal lung development. In: Voelkel NF, MacNee W. ed. Chronic obstructive lung diseases. BC Decker, Hamilton, Ontario 2002: 7–20.
- DiFiore JW, Wilson JM. Lung development. Semin Pediatr Surg. 1994; 3(4): 221–232.
- Dyer J. Neonatal respiratory distress syndrome: tackling a worldwide problem. P T. 2019; 44(1): 12–14.
- Fanaroff AA, Martin RJ. Neonatal-perinatal medicine: diseases of the fetus and infant. Elsevier, Philadelphia 1987.
- Gluck L, Kulovich MV, Borer RC, et al. Diagnosis of the respiratory distress syndrome by amniocentesis. Am J Obstet Gynecol. 1971; 109(3): 440–445.
- Goldenberg RL, Hauth JC, Andrews WW, et al. Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. Am J Obstet Gynecol. 1998; 178(3): 546–550.
- Goldmann T, Kähler D, Schultz H, et al. On the significance of surfactant protein-A within the human lungs. Diagn Pathol. 2009; 4: 8.
- Han S, Mallampalli RK. The role of surfactant in lung disease and host defense against pulmonary infections. Ann Am Thorac Soc. 2015; 12(5): 765–774.
- Honda T, Ishida K, Hayama M, et al. Type II pneumocytes are preferentially located along thick elastic fibers forming the framework of human alveoli. Anat Rec. 2000; 258(1): 34–38, doi: 10.1002/(SICI)1097-0185(20000101)258:1<34::AID-AR4>3.0.CO;2-7.
- Hubbard RM, Choudhury KM, Lim G. Treatment patterns and clinical outcomes in neonates diagnosed with respiratory distress syndrome in a low-income country: a report from bangladesh. Anesth Analg. 2018; 126(5): 1684–1686.
- Jain D, Dodia C, Fisher AB, et al. Pathways for clearance of surfactant protein A from the lung. Am J Physiol Lung Cell Mol Physiol. 2005; 289(6): L1011–L1018.
- Janssens JP, Pache JC, Nicod LP. Physiological changes in respiratory function associated with ageing. Eur Respir J. 1999; 13(1): 197–205.
- Kate DR, Sant SM. Histogenesis of human foetal lung: a light microscopic study. IOSR J Dent Med Sci. 2013; 9(2): 01–08.
- Kuroki Y, Dempo K, Akino T. Immunohistochemical study of human pulmonary surfactant apoproteins with monoclonal antibodies. Pathologic application for hyaline membrane disease. Am J Pathol. 1986; 124(1): 25–33.
- Kuroki Y, Akino T. Pulmonary surfactant protein A (SP-A) specifically binds dipalmitoylphosphatidylcholine. J Biol Chem. 1991; 266(5): 3068–3073.
- Laudy JA, Wladimiroff JW. The fetal lung. 1: developmental aspects. Ultrasound Obstet Gynecol. 2000; 16(3): 284–290.
- Lwanga SK, Lemeshow S. WHO. Sample size determination in health studies: a practical manual. World Health Organization, Geneva 1991.
- McFetridge L, McMorrow A, Morrison PJ, et al. Surfactant metabolism dysfunction and childhood interstitial lung disease (chILD). Ulster Med J. 2009; 78(1): 7–9.
- Melén E, Guerra S. Recent advances in understanding lung function development. F1000Res. 2017; 6: 726.
- Meng X, Cui G, Peng G. Lung development and regeneration: newly defined cell types and progenitor status. Cell Regen. 2023; 12(1): 5.
- Nikolić MZ, Sun D, Rawlins EL. Human lung development: recent progress and new challenges. Development. 2018; 145(16).
- Pryhuber GS, Hull WM, Fink I, et al. Ontogeny of surfactant proteins A and B in human amniotic fluid as indices of fetal lung maturity. Pediatr Res. 1991; 30(6): 597–605.
- Randell SH, Young S. Structure of alveolar epithelial cells and the surface layer during development. Fetal Neonatal Physiol. 2011: 1115–1122.
- Sadler TW. Langman's medical embryology. Lippincott Williams & Wilkins, Philadelphia 2022.
- Schittny JC. Development of the lung. Cell Tissue Res. 2017; 367(3): 427–444.
- Singh G, Katyal SL. Surfactant apoprotein in nonmalignant pulmonary disorders. Am J Pathol. 1980; 101(1): 51–61.
- Sun AP, Ohtsuki Y, Fujita J, et al. KL-6, a human MUC1 mucin, is expressed early in premature lung. Respir Med. 2003; 97(8): 964–969.
- Szpinda M, Szpinda M. The normal growth of the pulmonary trunk in human foetuses. Folia Morphol. 2007; 66(2): 126–130.
- Whitsett JA, Wert SE, Weaver TE. Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annu Rev Med. 2010; 61: 105–119.
